EDVANYSEBeveragesFiscal year ends December 31
Endovia Health Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)
Close on Oct 19, 2026
- Market cap
- $413.76K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 19, 2026(first seen in filings) | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Jul 27, 2026 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Jul 11, 2025(first seen in filings) | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Mar 28, 2025 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Jun 11, 2021 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |
| May 13, 2020(first seen in filings) | 13-for-4 | Earlier per-share figures divided by 3.25 |